AmniSure International

Qiagen acquires AmniSure International

Friday, May 4, 2012

Netherlands holding company Qiagen has acquired AmniSure International, a privately owned Boston company that markets the AmniSure assay for determining whether a pregnant woman is suffering rupture of fetal membranes (ROM), a condition in which fluid leaks from the amniotic sac prematurely. Financial terms were not disclosed.

[Read More]